Skip to main content
ChemPartner PharmaTech Co., Ltd. logo

ChemPartner PharmaTech Co., Ltd. — Investor Relations & Filings

Ticker · 300149 ISIN · CNE100000Y27 Shenzhen Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,256 across all filing types
Latest filing 2018-06-15 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300149

About ChemPartner PharmaTech Co., Ltd.

https://www.chempartner.com

ChemPartner PharmaTech Co., Ltd. is a global research and development organization providing comprehensive drug discovery and development services. Operating as a Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO), the company supports pharmaceutical and biotechnology clients through an integrated service platform. Core capabilities include medicinal chemistry, biology, pharmacology, drug metabolism and pharmacokinetics (DMPK), and toxicology. The organization also offers specialized expertise in biologics discovery, protein engineering, and antibody development. ChemPartner facilitates the transition from early-stage research to clinical development through its pharmaceutical development and manufacturing capabilities, utilizing advanced technology to accelerate the discovery and production of novel therapeutic agents.

Recent filings

Filing Released Lang Actions
关于股东部分股份解除质押的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (725 characters) about a shareholder partially releasing pledged shares. It includes details about the shareholder, number of shares released from pledge, dates, and percentages. There is no financial data, no report attached or referenced as being published, and no mention of a meeting or voting results. This fits the description of a Regulatory Filing (RNS) as it is a general regulatory announcement about share pledge status, not a full financial report or capital change announcement (since it is about pledge release, not share issuance or buyback).
2018-06-15 Chinese
关于重组完成后的战略规划及组织架构调整的公告
Board/Management Information Classification · 95% confidence The document is an announcement from a company about its strategic planning and organizational structure adjustment following a completed restructuring. It includes details about business focus areas and the establishment of new business units. The document is relatively short (1805 characters) and does not contain financial statements, audit information, or detailed financial data. It is not a report itself but an announcement of corporate strategy and organizational changes. This fits best under the category of Board/Management Information (MANG), which covers announcements of changes in company management or organizational structure.
2018-06-14 Chinese
独立董事工作制度（2018年6月）
Governance Information Classification · 95% confidence The document is titled '独立董事工作制度' which translates to 'Independent Director Work System'. It details the governance structure, qualifications, nomination, duties, rights, and obligations of independent directors in the company. It references relevant laws, regulations, and stock exchange rules, and outlines internal governance practices related to board members. There is no financial data, earnings information, or report publication announcement. The content is focused on governance practices and internal rules regarding board structure and director responsibilities. Therefore, this document fits the category of Governance Information (CGR). The document length (8063 characters) and detailed content support this classification with high confidence.
2018-06-14 Chinese
公司章程（2018年6月）
Governance Information Classification · 95% confidence The document is titled as the "章程" (Articles of Association or Company Bylaws) of Quantum Hi-Tech (China) Biological Co., Ltd. It contains detailed chapters on company organization, shareholder rights, board of directors, management, financial accounting, profit distribution, auditing, shareholder meetings, and other governance matters. The content is a comprehensive set of internal rules and regulations governing the company's structure and operations, including shareholder meetings, board responsibilities, and amendments to the articles. There is no indication that this is an annual report, financial statement, or an announcement of voting results. Instead, it is a governance document detailing the company's internal rules and governance practices. Therefore, the appropriate classification is Governance Information (CGR). The document length (15,000 characters) and detailed content support this classification with high confidence.
2018-06-14 Chinese
关于增加2018年度日常关联交易预计公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement regarding the increase in the estimated amount of daily related-party transactions for the year 2018 by Quantum Hi-Tech (China) Biological Co., Ltd. It includes descriptions of the related parties, transaction categories, amounts, pricing policies, and independent directors' opinions. The document is not a full financial report but rather a regulatory announcement about related-party transactions and their approval by the board and shareholders. It does not contain comprehensive financial statements or quarterly/yearly financial results. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2018-06-14 Chinese
关于增加使用闲置自有资金进行现金管理额度的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by Quantum Hi-Tech (China) Biological Co., Ltd. regarding an increase in the limit for using idle funds for cash management. It details the board and supervisory committee approvals, investment purpose, amount, types, risks, and control measures. The document is a formal public announcement about a financing/capital management decision, specifically about increasing the cash management quota for investing in low-risk financial products. It is not a financial report, earnings release, or regulatory certification. It is not a report publication announcement since it contains substantive information about the capital management decision. The content fits best under Capital/Financing Update (CAP) as it relates to changes in the company's capital usage and financing activities.
2018-06-14 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.